211 related articles for article (PubMed ID: 27334845)
1. 7-dehydrocholesterol efficiently supports Ret signaling in a mouse model of Smith-Opitz-Lemli syndrome.
Gou-Fàbregas M; Macià A; Anerillas C; Vaquero M; Jové M; Jain S; Ribera J; Encinas M
Sci Rep; 2016 Jun; 6():28534. PubMed ID: 27334845
[TBL] [Abstract][Full Text] [Related]
2. Cholesterol deficiency in a mouse model of Smith-Lemli-Opitz syndrome reveals increased mast cell responsiveness.
Kovarova M; Wassif CA; Odom S; Liao K; Porter FD; Rivera J
J Exp Med; 2006 May; 203(5):1161-71. PubMed ID: 16618793
[TBL] [Abstract][Full Text] [Related]
3. Lipid Rafts Are Physiologic Membrane Microdomains Necessary for the Morphogenic and Developmental Functions of Glial Cell Line-Derived Neurotrophic Factor In Vivo.
Tsui CC; Gabreski NA; Hein SJ; Pierchala BA
J Neurosci; 2015 Sep; 35(38):13233-43. PubMed ID: 26400951
[TBL] [Abstract][Full Text] [Related]
4. 7-Dehydrocholesterol-derived oxysterols cause neurogenic defects in Smith-Lemli-Opitz syndrome.
Tomita H; Hines KM; Herron JM; Li A; Baggett DW; Xu L
Elife; 2022 Sep; 11():. PubMed ID: 36111785
[TBL] [Abstract][Full Text] [Related]
5. DHCEO accumulation is a critical mediator of pathophysiology in a Smith-Lemli-Opitz syndrome model.
Xu L; Mirnics K; Bowman AB; Liu W; Da J; Porter NA; Korade Z
Neurobiol Dis; 2012 Mar; 45(3):923-9. PubMed ID: 22182693
[TBL] [Abstract][Full Text] [Related]
6. Antioxidant supplementation ameliorates molecular deficits in Smith-Lemli-Opitz syndrome.
Korade Z; Xu L; Harrison FE; Ahsen R; Hart SE; Folkes OM; Mirnics K; Porter NA
Biol Psychiatry; 2014 Feb; 75(3):215-22. PubMed ID: 23896203
[TBL] [Abstract][Full Text] [Related]
7. Modeling Smith-Lemli-Opitz syndrome with induced pluripotent stem cells reveals a causal role for Wnt/β-catenin defects in neuronal cholesterol synthesis phenotypes.
Francis KR; Ton AN; Xin Y; O'Halloran PE; Wassif CA; Malik N; Williams IM; Cluzeau CV; Trivedi NS; Pavan WJ; Cho W; Westphal H; Porter FD
Nat Med; 2016 Apr; 22(4):388-96. PubMed ID: 26998835
[TBL] [Abstract][Full Text] [Related]
8. Biological activities of 7-dehydrocholesterol-derived oxysterols: implications for Smith-Lemli-Opitz syndrome.
Korade Z; Xu L; Shelton R; Porter NA
J Lipid Res; 2010 Nov; 51(11):3259-69. PubMed ID: 20702862
[TBL] [Abstract][Full Text] [Related]
9. Cholesterol biosynthesis from birth to adulthood in a mouse model for 7-dehydrosterol reductase deficiency (Smith-Lemli-Opitz syndrome).
Marcos J; Shackleton CH; Buddhikot MM; Porter FD; Watson GL
Steroids; 2007 Oct; 72(11-12):802-8. PubMed ID: 17714750
[TBL] [Abstract][Full Text] [Related]
10. Development and characterization of a hypomorphic Smith-Lemli-Opitz syndrome mouse model and efficacy of simvastatin therapy.
Correa-Cerro LS; Wassif CA; Kratz L; Miller GF; Munasinghe JP; Grinberg A; Fliesler SJ; Porter FD
Hum Mol Genet; 2006 Mar; 15(6):839-51. PubMed ID: 16446309
[TBL] [Abstract][Full Text] [Related]
11. Glial cell line-derived neurotrophic factor-dependent recruitment of Ret into lipid rafts enhances signaling by partitioning Ret from proteasome-dependent degradation.
Pierchala BA; Milbrandt J; Johnson EM
J Neurosci; 2006 Mar; 26(10):2777-87. PubMed ID: 16525057
[TBL] [Abstract][Full Text] [Related]
12. 7-Dehydrocholesterol-dependent proteolysis of HMG-CoA reductase suppresses sterol biosynthesis in a mouse model of Smith-Lemli-Opitz/RSH syndrome.
Fitzky BU; Moebius FF; Asaoka H; Waage-Baudet H; Xu L; Xu G; Maeda N; Kluckman K; Hiller S; Yu H; Batta AK; Shefer S; Chen T; Salen G; Sulik K; Simoni RD; Ness GC; Glossmann H; Patel SB; Tint GS
J Clin Invest; 2001 Sep; 108(6):905-15. PubMed ID: 11560960
[TBL] [Abstract][Full Text] [Related]
13. Reduced cholesterol levels impair Smoothened activation in Smith-Lemli-Opitz syndrome.
Blassberg R; Macrae JI; Briscoe J; Jacob J
Hum Mol Genet; 2016 Feb; 25(4):693-705. PubMed ID: 26685159
[TBL] [Abstract][Full Text] [Related]
14. Oxidative stress, serotonergic changes and decreased ultrasonic vocalizations in a mouse model of Smith-Lemli-Opitz syndrome.
Sharif NF; Korade Z; Porter NA; Harrison FE
Genes Brain Behav; 2017 Jul; 16(6):619-626. PubMed ID: 28220990
[TBL] [Abstract][Full Text] [Related]
15. Lipid Raft-Excluded GFRα1/Ret Fails to Transmit GDNF Signaling In Vivo.
Morales D
J Neurosci; 2016 Feb; 36(5):1442-4. PubMed ID: 26843628
[No Abstract] [Full Text] [Related]
16. Formation of 7-dehydrocholesterol-containing membrane rafts in vitro and in vivo, with relevance to the Smith-Lemli-Opitz syndrome.
Keller RK; Arnold TP; Fliesler SJ
J Lipid Res; 2004 Feb; 45(2):347-55. PubMed ID: 14594996
[TBL] [Abstract][Full Text] [Related]
17. Residual cholesterol synthesis and simvastatin induction of cholesterol synthesis in Smith-Lemli-Opitz syndrome fibroblasts.
Wassif CA; Krakowiak PA; Wright BS; Gewandter JS; Sterner AL; Javitt N; Yergey AL; Porter FD
Mol Genet Metab; 2005 Jun; 85(2):96-107. PubMed ID: 15896653
[TBL] [Abstract][Full Text] [Related]
18. Lowered DHCR7 activity measured by ergosterol conversion in multiple cell types in Smith-Lemli-Opitz syndrome.
Ginat S; Battaile KP; Battaile BC; Maslen C; Gibson KM; Steiner RD
Mol Genet Metab; 2004; 83(1-2):175-83. PubMed ID: 15464432
[TBL] [Abstract][Full Text] [Related]
19. An oxysterol biomarker for 7-dehydrocholesterol oxidation in cell/mouse models for Smith-Lemli-Opitz syndrome.
Xu L; Korade Z; Rosado JDA; Liu W; Lamberson CR; Porter NA
J Lipid Res; 2011 Jun; 52(6):1222-1233. PubMed ID: 21402677
[TBL] [Abstract][Full Text] [Related]
20. Peroxisomal cholesterol biosynthesis and Smith-Lemli-Opitz syndrome.
Weinhofer I; Kunze M; Stangl H; Porter FD; Berger J
Biochem Biophys Res Commun; 2006 Jun; 345(1):205-9. PubMed ID: 16678134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
